Logo image of OPK

OPKO HEALTH INC (OPK) Stock Fundamental Analysis

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.42  0 (0%)

After market: 1.43 +0.01 (+0.7%)

Fundamental Rating

2

OPK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 106 industry peers in the Health Care Providers & Services industry. While OPK seems to be doing ok healthwise, there are quite some concerns on its profitability. OPK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OPK had negative earnings in the past year.
OPK had a negative operating cash flow in the past year.
In the past 5 years OPK reported 4 times negative net income.
In multiple years OPK reported negative operating cash flow during the last 5 years.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.42%, OPK is in line with its industry, outperforming 44.34% of the companies in the same industry.
OPK's Return On Equity of -3.90% is in line compared to the rest of the industry. OPK outperforms 48.11% of its industry peers.
Industry RankSector Rank
ROA -2.42%
ROE -3.9%
ROIC N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

OPK's Gross Margin of 30.64% is in line compared to the rest of the industry. OPK outperforms 54.72% of its industry peers.
In the last couple of years the Gross Margin of OPK has declined.
OPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPK has been reduced compared to 1 year ago.
The number of shares outstanding for OPK has been increased compared to 5 years ago.
OPK has a worse debt/assets ratio than last year.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of -0.46, we must say that OPK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.46, OPK is doing worse than 80.19% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that OPK is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.31, OPK is doing good in the industry, outperforming 63.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -0.46
ROIC/WACCN/A
WACC8.18%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

OPK has a Current Ratio of 3.43. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.43, OPK belongs to the top of the industry, outperforming 88.68% of the companies in the same industry.
A Quick Ratio of 3.13 indicates that OPK has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.13, OPK belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.43
Quick Ratio 3.13
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

OPK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.66%, which is quite good.
Looking at the last year, OPK shows a very negative growth in Revenue. The Revenue has decreased by -17.41% in the last year.
The Revenue has been decreasing by -4.59% on average over the past years.
EPS 1Y (TTM)14.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)-17.41%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%0.93%

3.2 Future

OPK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.73% yearly.
Based on estimates for the next years, OPK will show a small growth in Revenue. The Revenue will grow by 7.69% on average per year.
EPS Next Y-50.7%
EPS Next 2Y-5.63%
EPS Next 3Y13.73%
EPS Next 5YN/A
Revenue Next Year-3.27%
Revenue Next 2Y2.26%
Revenue Next 3Y6.29%
Revenue Next 5Y7.69%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

OPK's earnings are expected to grow with 13.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.63%
EPS Next 3Y13.73%

More info and screens

0

5. Dividend

5.1 Amount

OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPKO HEALTH INC

NASDAQ:OPK (4/17/2025, 8:00:02 PM)

After market: 1.43 +0.01 (+0.7%)

1.42

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners29.22%
Inst Owner Change0%
Ins Owners6.21%
Ins Owner Change0%
Market Cap953.67M
Analysts86
Price Target4.07 (186.62%)
Short Float %29.89%
Short Ratio17.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.57%
Min EPS beat(2)4.52%
Max EPS beat(2)110.61%
EPS beat(4)3
Avg EPS beat(4)44.91%
Min EPS beat(4)-25.07%
Max EPS beat(4)110.61%
EPS beat(8)5
Avg EPS beat(8)38.45%
EPS beat(12)6
Avg EPS beat(12)-132.69%
EPS beat(16)8
Avg EPS beat(16)-130.54%
Revenue beat(2)1
Avg Revenue beat(2)5.83%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)16.97%
Revenue beat(4)1
Avg Revenue beat(4)0.76%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)16.97%
Revenue beat(8)5
Avg Revenue beat(8)7.18%
Revenue beat(12)6
Avg Revenue beat(12)4.61%
Revenue beat(16)9
Avg Revenue beat(16)6.7%
PT rev (1m)0.84%
PT rev (3m)0.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.38%
EPS NY rev (1m)-6.82%
EPS NY rev (3m)-8.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.33%
Revenue NY rev (1m)-3.72%
Revenue NY rev (3m)-3.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.34
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 38.79
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS1.06
BVpS2.03
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.42%
ROE -3.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.64%
FCFM N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
F-Score2
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.47%
Cap/Sales 3.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.43
Quick Ratio 3.13
Altman-Z -0.46
F-Score2
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)28.79%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y-50.7%
EPS Next 2Y-5.63%
EPS Next 3Y13.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.41%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%0.93%
Revenue Next Year-3.27%
Revenue Next 2Y2.26%
Revenue Next 3Y6.29%
Revenue Next 5Y7.69%
EBIT growth 1Y-74.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.82%
EBIT Next 3Y32.8%
EBIT Next 5Y26.89%
FCF growth 1Y-368.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-550.74%
OCF growth 3YN/A
OCF growth 5YN/A